8-K: Personalis, Inc. Amends At-the-Market Sales Agreement, Adds Piper Sandler as Sales Agent

Personalis, Inc. has amended its at-the-market sales agreement to include Piper Sandler & Co. as a sales agent, allowing the company to offer and sell shares of its common stock.

Summary

• Personalis, Inc. has entered into an amended and restated at-the-market sales agreement with Piper Sandler & Co. and BTIG, LLC.
• The amended agreement adds Piper Sandler as a sales agent, joining BTIG, LLC.
• The company may offer and sell shares of its common stock from time to time through these sales agents.
• The previous sales agreement with BTIG, LLC, dated December 30, 2021, and amended on December 21, 2023, is now superseded by this new agreement.
• A prospectus supplement related to this offering was filed on December 27, 2024.
• The previous offering of common stock under the sales agreement prospectus dated January 9, 2024, has been terminated.

Sentiment

Score: 7

Explanation: The document is a routine financial announcement about an amendment to an existing agreement. It is positive in that it provides the company with more flexibility to raise capital, but it is not a major event that would significantly impact the company's prospects.

Positives

• The company has expanded its options for raising capital by adding a new sales agent.
• The amended agreement provides flexibility for the company to sell shares over time.

Risks

• The company's ability to sell shares under the agreement is subject to market conditions and other factors.
• There is no guarantee that the company will be able to sell all the shares it intends to offer.

Future Outlook

The company intends to sell shares of its common stock through the sales agents from time to time, subject to market conditions and other factors.

Industry Context

At-the-market offerings are a common way for companies to raise capital, providing flexibility and potentially reducing the impact on the stock price compared to traditional offerings. The addition of Piper Sandler as a sales agent could indicate an effort to broaden the reach of the offering.

Comparison to Industry Standards

• At-the-market (ATM) offerings are a common financing tool used by publicly traded companies, particularly in the biotech and healthcare sectors, to raise capital opportunistically.
• Comparable companies such as Adaptive Biotechnologies, Guardant Health, and Exact Sciences have utilized ATM programs to fund operations and growth initiatives.
• The commission rate of 3% is within the typical range for ATM offerings, which can vary based on the size and complexity of the offering.
• The inclusion of multiple sales agents, such as Piper Sandler and BTIG, is also a common practice to increase the potential reach and efficiency of the offering.

Stakeholder Impact

• Shareholders may experience dilution if the company sells a significant number of shares.
• The company will have access to additional capital to fund its operations and growth.

Next Steps

• The company will offer and sell shares of its common stock through the sales agents.
• The company will file required reports with the SEC and the Exchange.

Key Dates

Keywords

at-the-market offering, common stock, sales agreement, Piper Sandler, BTIG, capital raise, securities offering, prospectus supplement